MIPS Company Profile

05:56 EST 11th December 2018 | BioPortfolio

Founded in Flanders (Belgium) in 1985 and headquartered in Gent, MIPS has rapidly developed into one of the leading, privately held European Medical Information enterprises for clinical laboratories. MIPS' versatility and commitment to quality is proven by its broad range of customers. MIPS Laboratory Information Management Systems are fully operational throughout Europe. Hospitals and private environments are equally represented. Daily test volumes range from 500 to over 80,000.
MIPS' strategy is to offer computing power to every laboratory by means of standardized software and service. Using today's state of the art database, networking and user interface technologies, MIPS has developed a cutting edge laboratory information management system that is both effective and affordable for laboratories of any type or size.
In its niche market of clinical laboratory information management systems, MIPS is very well respected as a supplier with an extremely flexible product and with highly qualified and experienced staff, eager to assist even the most complex organizations with the most challenging deadlines.
In 2005, MIPS has merged with CliniSys, a leading UK provider of laboratory information management systems (LIMS) and chronic disease management applications. As part of a larger group both businesses will benefit from significantly increased resources supported by 200 LIMS and medical specialists.


Industriepark Zwijnaarde 3A


Phone: 32 (9) 220.23.21
Fax: 32 (9) 220.48.10

News Articles [30 Associated News Articles listed on BioPortfolio]

New Research Reveals MIPS Confusion Among Physicians

Rajiv LeventhalA survey of internal medicine physicians has revealed low levels of familiarity with the Merit-based Incentive Payment System (MIPS), with some respondents also believing that MIPS requ...

CMS Extends Deadline for MIPS Targeted Review to October 1, 2018

Status Tool for 2018 Qualifying APM Participant and MIPS APMs Data Now Available If you participate in the Merit-based Incentive Payment System (MIPS), you should have reviewed your 2017 performance f...

Most 2017 Participants in MIPS Qualified for Small Bonus

CMS says over 90% of clinician participants in MIPS in 2017 earned positive ratings. Medscape Medical News

MedPAC Wants MIPS to Go Away. Should the Group Get Its Way?

The powerful independent congressional agency known as MedPAC, the Medicare Payment Advisory Commission, has recommended that MIPS be scrapped. Should the influential group get its way?

CMS Hits MIPS Participation Goal for Year One

Rajiv LeventhalAccording to CMS Administrator Seema Verma, 91 percent of all Merit-based Incentive Payment System (MIPS)-eligible clinicians participated in the first year of the Quality Payment Progr...

Most clinicians in MIPS earned small payment bump in first year results

CMS issued its year one performance results for participants in the Merit-based Incentive Payment System (MIPS), revealing that 93 percent of eligible clinicians received at least some positive pay...

Aidoc, SaferMD partner to offer AI-based solution for increasing MIPS scores

Aidoc and SaferMD are joining forces for a new solution that will use artificial intelligence (AI) to improve clinical results and give radiologists higher Medicare Merit-Based Incentive Payments...

CMS: 93% of Clinicians Get Positive Payment Adjustments for MIPS Year 1

Rajiv Leventhal, Managing EditorNinety-three percent of MIPS-eligible clinicians received a positive payment adjustment for their performance in 2017, and 95 percent overall avoided a negative payment...

Drugs and Medications [0 Results]


PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.

Micropapillary structures (MIPs) are focal piles of columnar cells without extracellular matrix contact, and common in serrated colorectal carcinoma (CRC). In order to characterize biology of MIPs in ...

MIRATE: MIps RATional dEsign Science Gateway.

Molecularly imprinted polymers (MIPs) are high affinity robust synthetic receptors, which can be optimally synthesized and manufactured more economically than their biological equivalents (i.e. antibo...

Development of molecularly imprinted polymers to block quorum sensing and inhibit bacterial biofilm formation.

Bacterial biofilms are responsible for most clinical infections and show increased antimicrobial resistance. In this study, molecularly imprinted polymers (MIPs) were developed to specifically capture...

Carbon dots coated with molecularly imprinted polymers: A facile bioprobe for fluorescent determination of caffeic acid.

A new and sensitive method for fluorescent determination of caffeic acid (CA) was proposed based on silane-functionazed carbon dots coated with molecularly imprinted polymers (CDs@MIPs). CDs@MIPs were...

The Results Are In: Physicians Finally See How They Fared in First Year of MIPS.

Physicians finally see how they fared in the first year of Medicare's "MIPS" quality payment program.

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS)

The objective of the study is to compare the outcomes after a surgical procedure with minimally invasive Ponto surgery (MIPS, test group) and tissue preservation surgery (control) for plac...

Effect of Body Position on Spirometry in Abdominal Obesity.

Objective: Study the effect of body position on spirometry in obese patients as defined by waist to hip ratio (WHR) of greater than 0.85 in women, and 0.9 in men Background: Spirometry is...

Companies [1 Associated Companies listed on BioPortfolio]


Founded in Flanders (Belgium) in 1985 and headquartered in Gent, MIPS has rapidly developed into one of the leading, privately held European Medical Information enterprises for clinical laboratories. ...

More Information about "MIPS" on BioPortfolio

We have published hundreds of MIPS news stories on BioPortfolio along with dozens of MIPS Clinical Trials and PubMed Articles about MIPS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MIPS Companies in our database. You can also find out about relevant MIPS Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record